Carcinoembryonic Antigen: A Potential Biomarker to Evaluate the Severity and Prognosis of COVID-19

Background and Objectives: Corona Virus Disease 2019 (COVID-19) has become a serious pandemic disease worldwide. Identification of biomarkers to predict severity and prognosis is urgently needed for early medical intervention due to high mortality of critical cases with COVID-19. This retrospective study aimed to indicate the values of carcinoembryonic antigen (CEA) in evaluating the severity and prognosis of COVID-19. Methods: We included 46 death cases from intensive care unit and 68 discharged cases from ordinary units with confirmed COVID-19 of Wuhan Jin Yin-tan Hospital from January 1 to March 22, 2020. Laboratory and radiologic data were analyzed retrospectively. All patients were followed up until April 10, 2020. Results: COVID-19 patients in the death group had significantly higher CEA levels (ng/ml) than discharged group (14.80 ± 14.20 vs. 3.80 ± 2.43, P < 0.001). The risk of COVID-19 death increased 1.317 times for each additional 1 ng/ml CEA level (OR = 1.317, 95% CI: 1.099–1.579). The standardized and weighted receiver operating characteristic curve (ROC) analysis adjusted to age, sex, and ferritin levels suggested that the area under the curve (AUC) of the serum CEA levels was 0.808 in discrimination between death cases and discharged cases with COVID-19 (P < 0.001). We found mortality of COVID-19 is associated with elevated CEA levels increased (HR = 1.023, 95% CI: 1.005–1.042), as well as age (HR = 1.050, 95% CI: 1.016–1.086) and ferritin levels (HR = 1.001, 95% CI: 1.001–1.002) by survival analysis of Cox regression model. Among discharged patients, CEA levels were significant lower in moderate cases compared to the severe and critical cases (P = 0.005; OR = 0.488, 95% CI: 0.294–0.808) from binary logistic regression analysis. The AUC of CEA levels was 0.79 in distinguishing moderate cases from discharged COVID-19 patients by standardized and weighted ROC analysis (P < 0.001). A positive correlation between CEA levels and CT scores existed in discharged patients (Correlation Coefficient: 0.687; P < 0.001). Conclusions: Elevated CEA levels increased the risk of death from COVID-19 and CEA levels were related to CT scores of the discharged patients positively.

[1]  Y. Hu,et al.  [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[2]  M. Delpino,et al.  SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis , 2020, Frontiers in Cellular and Infection Microbiology.

[3]  R. V. Vander Heide,et al.  Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans , 2020, The Lancet Respiratory Medicine.

[4]  A. Wells,et al.  Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy , 2020, The Lancet Respiratory Medicine.

[5]  G. Kai,et al.  COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons , 2020, Cytokine & Growth Factor Reviews.

[6]  Kunyu Yang,et al.  Elevations of serum cancer biomarkers correlate with severity of COVID‐19 , 2020, Journal of medical virology.

[7]  Kenji Suzuki,et al.  P2‐18: Establishment of acquired pemetrexed‐resistant MPM cell lines and evaluation of an IGF‐1R inhibitor picropodophyllin for MPM treatment , 2020, Respiratory investigation.

[8]  J. Qu,et al.  Interpretations of “Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7)” , 2020, Chinese medical journal.

[9]  Chaochao Tan,et al.  C‐reactive protein correlates with computed tomographic findings and predicts severe COVID‐19 early , 2020, Journal of medical virology.

[10]  Huan Li,et al.  Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis , 2020, Journal of Infection.

[11]  K. Yuen,et al.  Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2 , 2020, Cell.

[12]  G. Soraya,et al.  Interleukin-6 as a potential biomarker of COVID-19 progression , 2020, Médecine et Maladies Infectieuses.

[13]  U. Jha,et al.  A review of the 2019 novel coronavirus (COVID-19) based on current evidence , 2020 .

[14]  J. Alam.  Buying Behavior Under Coronavirus Disease (COVID-19) Pandemic Situation: A Online Perspective Case in Bangladeshi Shoppers , 2020 .

[15]  S. Xiao,et al.  Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies , 2020, Modern Pathology.

[16]  X. Bian,et al.  [A pathological report of three COVID-19 cases by minimally invasive autopsies]. , 2020, Zhonghua bing li xue za zhi = Chinese journal of pathology.

[17]  A. M. Leontovich,et al.  The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 , 2020, Nature Microbiology.

[18]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[19]  Haibo Xu,et al.  Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer , 2020, Journal of Thoracic Oncology.

[20]  R. Agha,et al.  World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19) , 2020, International Journal of Surgery.

[21]  P. Liu,et al.  Gross examination report of a COVID-19 death autopsy. , 2020, Fa yi xue za zhi.

[22]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[23]  Dengju Li,et al.  Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia , 2020, Journal of Thrombosis and Haemostasis.

[24]  Jun Liu,et al.  Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing , 2020, Radiology.

[25]  Kai Zhao,et al.  A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.

[26]  K. Crandall,et al.  Mutated CEACAMs Disrupt Transforming Growth Factor beta Signaling and Alter the Intestinal Microbiome to Promote Colorectal Carcinogenesis. , 2019, Gastroenterology.

[27]  S. Walsh,et al.  Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. , 2019, The New England journal of medicine.

[28]  D. Galetta,et al.  Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial. , 2019, Lung cancer.

[29]  B. Giraudeau,et al.  Standardized and weighted time-dependent receiver operating characteristic curves to evaluate the intrinsic prognostic capacities of a marker by taking into account confounding factors , 2018, Statistical methods in medical research.

[30]  S. Gray-Owen,et al.  Specific Binding to Differentially Expressed Human Carcinoembryonic Antigen-Related Cell Adhesion Molecules Determines the Outcome of Neisseria gonorrhoeae Infections along the Female Reproductive Tract , 2018, Infection and Immunity.

[31]  C. Tempfer,et al.  Accuracy of intrapartum fetal blood gas analysis by scalp sampling , 2017, Medicine.

[32]  A. Ajlan,et al.  Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings. , 2014, AJR. American journal of roentgenology.

[33]  S. S. Syed Sulaiman,et al.  Development of an Adverse Drug Reaction Risk Assessment Score among Hospitalized Patients with Chronic Kidney Disease , 2014, PloS one.

[34]  C. Hauck,et al.  Signaling by epithelial members of the CEACAM family – mucosal docking sites for pathogenic bacteria , 2014, Cell Communication and Signaling.

[35]  N. Beauchemin,et al.  Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis , 2013, Cancer and Metastasis Reviews.

[36]  Michael J. Cronce,et al.  Type 2 alveolar cells are stem cells in adult lung. , 2013, The Journal of clinical investigation.

[37]  A. Morice,et al.  Serum carcinoembryonic antigen correlates with severity of idiopathic pulmonary fibrosis , 2012, Respirology.

[38]  N. Obuchowski,et al.  Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures , 2010, Epidemiology.

[39]  C. Stanners,et al.  A co‐clustering model involving α5β1 integrin for the biological effects of GPI‐anchored human carcinoembryonic antigen (CEA) , 2007 .

[40]  M. Papotti,et al.  Immunohistochemical Detection of Carcinoembryonic Antigen (CEA) in non-neoplastic Lung Disease , 1993, The International journal of biological markers.

[41]  Cui Hao,et al.  Serum CEA levels in 49 different types of cancer and noncancer diseases. , 2019, Progress in molecular biology and translational science.

[42]  V. Thannickal,et al.  Novel Mechanisms for the Antifibrotic Action of Nintedanib. , 2016, American journal of respiratory cell and molecular biology.

[43]  K. Uematsu,et al.  Evaluation of serum levels of carcinoembryonic antigen in allergic bronchopulmonary aspergillosis. , 2013, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[44]  The Journal of Pharmacology and Experimental Therapeutics The triple angiokinase inhibitor nintedanib directly inhibits tumor cell growth and induces tumor shrinkage via blocking oncogenic receptor tyrosine kinases , 2022 .